Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
British Journal of Haematology|January 25, 2022
Platelets modulate CD4+ T-cell function in COVID-19 through a PD-L1 dependent mechanismAna Paletta, Facundo Di Diego García, Augusto Varese, et al.
Frontiers in Immunology|March 17, 2022
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in MiceLorena M Coria, Lucas M Saposnik, Celeste Pueblas Castro, et al.
The Journal of Infectious Diseases|June 20, 2022
Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody ResponseAugusto Varese, Bianca Mazzitelli, Fernando Erra Díaz, et al.
Nature Communications|July 28, 2023
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adultsKarina A Pasquevich, Lorena M Coria, Ana Ceballos, et al.
Ebiomedicine|August 21, 2022
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort studyVanesa Seery, Silvina Raiden, Constanza Russo, et al.
Cell Reports. Medicine|July 26, 2021
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single doseAndres H Rossi, Diego S Ojeda, Augusto Varese, et al.
Ebiomedicine|October 14, 2021
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in childrenInés Sananez, Silvina C Raiden, Silvia C Algieri, et al.
Cell Reports. Medicine|August 4, 2022
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273Carla A Pascuale, Augusto Varese, Diego S Ojeda, et al.
Mbio|January 25, 2022
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over TimeMaría M Gonzalez Lopez Ledesma, Lautaro Sanchez, Diego S Ojeda, et al.
Pageof 2